API australian pharmaceutical industries limited

Tepid earnings growth, the mislaid $17.2m; cited that takeover...

  1. 56,901 Posts.
    lightbulb Created with Sketch. 288
    Tepid earnings growth, the mislaid $17.2m; cited that takeover rumours pushed her up recently; finally, they rate the stock as being "expensive". FYI.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.